NEW YORK, Oct. 11, 2012 Reportlinker.com announces that a new market research report is available in its catalogue: <\/p>\n
Global Markets for Treatments of Dementia and Movement Disorders — Focus on Movement Disorders http:\/\/www.reportlinker.com\/p01009663\/Global-Markets-for-Treatments-of-Dementia-and-Movement-Disorders—-Focus-on-Movement-Disorders.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology<\/a> <\/p>\n INTRODUCTION <\/p>\n STUDY OBJECTIVES <\/p>\n BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global markets for treatments for syndromes of dementia and movement disorders. The key objective is to present a comprehensive analysis and the future direction of the market as it shapes drug and therapy development. <\/p>\n This report explores present and future strategies within the neurodegenerative disorder market, which includes treatments and therapies for progressive dementia, progressive dementia with other neurological abnormalities and movement disorders. Market gains, setbacks and needs are discussed in this report. Comparisons, usage and the advantages and disadvantages of different types of technologies, including small molecules and monoclonal antibodies, are also presented in this report. <\/p>\n A detailed analysis of the structure of the syndromes of dementia and movement disorder industry has been conducted. Revenues are broken down by neurodegenerative disease and primary clinical\/pathological feature. Sales figures are estimated for the five-year period from 2012 through 2017. <\/p>\n Applications for syndromes of dementia and movement disorder treatments, or therapeutic technologies, are also discussed separately in the report, with an emphasis on small molecule and monoclonal antibodies technology. The report also covers significant patents and their allotment in each category. <\/p>\n REASONS FOR DOING THIS STUDY <\/p>\n Extensive research in the field of syndromes of dementia and movement disorders and company collaborations with research institutes have highlighted the importance of understanding the nature of these disorders. New technological developments are providing disease-modifying therapies for the late stages of the disorders. Collaborations between research institutes and pharmaceutical companies are on the rise as state-of-the-art technology is being explored to develop more efficient products and therapies. R&D spending, along with increasing competition, patent expiries and new technologies are taking the market in a new direction. Global market revenues increased from 2009 to 2011 and are expected to continue to show growth over the forecast period as new advances, launches and collaborations continue to influence the market. This study looks at most of the systems affected by these factors. Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of each type of technology in light of the new technologies, growing competition and changing customer needs. <\/p>\n<\/p>\n See the rest here: Source: NEW YORK, Oct. 11, 2012 Reportlinker.com announces that a new market research report is available in its catalogue: Global Markets for Treatments of Dementia and Movement Disorders — Focus on Movement Disorders http:\/\/www.reportlinker.com\/p01009663\/Global-Markets-for-Treatments-of-Dementia-and-Movement-Disorders—-Focus-on-Movement-Disorders.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology<\/a> INTRODUCTION STUDY OBJECTIVES BCC’s goal in conducting … Continue reading
\nGlobal Markets for Treatments of Dementia and Movement Disorders — Focus on Movement Disorders<\/a><\/p>\n
http:\/\/www.longevitymedicine.tv\/global-markets-for-treatments-of-dementia-and-movement-disorders-focus-on-movement-disorders\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"